{
  "trial_id": "NCT03023059",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "A diagnosis of AMD with choroidal neovascularization (CNV) in one eye",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "a. Not previously treated with anti-VEGF injections; or b. On anti-VEGF injections for at least 3 months, and meets criteria for a repeat injection; or c. Patients, who have completed Study 001, may enter this trial at the point of initiation of the month of treatment with the dose of carbidopa-levodopa, that they received in Study 001",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Normal or dry AMD of any grade in the second eye",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Willingness to maintain AREDS vitamin supplements throughout the study, or remain off these supplements for the duration of the study, if not taking them prior to the study",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Informed Consent at Baseline",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Any current use of L-DOPA containing medication or dopamine agonist medication, or any planned use of any of these agents, except for study medication, during the study",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Concurrent use of monoamine oxidase (MAO) inhibitors",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Any eye condition, disease, or history of trauma in either eye, which can impair vision, except cataract or cataract surgery",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "BCVA worse than 20/60 in the better eye",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Wet AMD in the second eye",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Neurologic conditions which can impair vision",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Parkinson's Disease",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Significant orthostatic hypotension, defined as a drop in systolic blood pressure, immediately upon changing from the supine to standing position, of >19 mmHg, or a symptomatic drop in systolic blood pressure, immediately upon changing from the supine to standing position",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has Parkinson's Disease and is on Levodopa and Trihexyphenidyl. He experiences slowness of movement and tremors.",
  "_meta": {
    "topic_id": "41",
    "trial_id": "NCT03023059",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}